SOSV is a global venture capital firm that offers multi-stage investment starting in deeply resourced, deep tech startup programs, IndieBio and HAX, with a focus on industrial automation, climate tech, health tech, and manufacturing.

SOSV

dlab

IndieBio

Orbit Startups

Genesis Consortium

SOSV is a global venture capital firm that operates early stage startup development programs.
 
SOSV’s programs are focused on revolutionary deep technology that promises the betterment of humanity and the planet.

The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, Series A, and later rounds while providing founders with ongoing support and community. 

As of January 2022, SOSV had more than 1,000 portfolio companies and $1.5 billion in assets under management, reflecting a 40% increase over 2020.

SOSV’s programs include hard tech-oriented HAX and life-science driven IndieBio. Both offer deep technical and scientific expertise on-site as well as well-equipped lab and fabrication facilities and supply chain access. 

Among the top companies in SOSV’s portfolio are NotCo, Upside Foods, Unspun, Opentrons, Mycoworks, and Prime Roots. 

SOSV releases the annual Human Health 100, a list of the firm’s top human health investments in areas ranging from assistive robotics to therapeutics and diagnostics. 

SOSV also publishes the annual Climate Tech 100, a list of the firm’s top climate-focused investments working on solutions to climate change across five sectors: food, manufacturing, transport, energy, and building systems. 

Osiris Therapeutics

Crowd Supply

DOWN

Powerhouse Dynamics

Roadie

Shaper

Bombfell

CanGo

DolphinChat

Adore Me

AiSight

ANA Therapeutics

Getaround

Harmonix Music Systems

JUMP Bikes

Kindara

Leap Motion

migme

Motiv

MyRobin.id

Our managing GP Sean O'Sullivan penned his 2024 outlook for deep tech. Bottom line? We've never been more bullish.  

Forget about the VC contraction; we will remember this era for the incredible (and essential) deep tech breakthroughs across all our means of production.  

We're also seeing climate tech in particular driving the deep tech category forward, and a rise in CVCs and governments interested in new manufacturing technologies. 

Read Sean's full take here: https://lnkd.in/dyGh3AVu

This week on the My Climate Journey podcast, Cody welcomed two guests to the show: 👩‍💻 Susan Schofer is a partner at SOSV and Chief Science Officer at HAX, SOSV's hard tech program. And 👨‍🔬 Po Bronson is General Partner at SOSV and Managing Director at IndieBio, SOSV's biotech program. 

We cover a ton of ground including: 
🧬 The complexity of evaluating material science startups
💡 Comparing Hax's and IndieBio's methodologies
📈 Scaling challenges in sustainable startups
🧪 The critical role of performance in bio-based materials

And tons more! Listen to the full episode wherever you get podcasts or at the link in the comments below. 

#materialscience #hardtech #biotech #startups 

Scientists! Engineers! Looking for a really demanding job at the cutting edge? SOSV has one of the largest deep tech startup portfolios, thanks to our startup development program IndieBio and HAX, and our companies are always hiring. Check out our portfolio company listings on our job boards. https://lnkd.in/dbKp7bsR

🌍 Join Pae W and SOSV at the Hello Tomorrow Global Summit 2024 in Paris on March 21 & 22! Pae will be speaking on the power of synthetic biology to reimagine and reinvent the world as we know it—sustainably. 

The Summit convenes 3,000 people around the globe who believe that science and technology hold untapped potential to solve our planet and society’s most urgent challenges. Join them: https://bit.ly/3sCDDYh

COM:SOSV

SOSV

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

monthly webtraffic

monthly webtraffic growth

Description

peer of

invested in

investor of

competitor of

Metrics